EUVIMEDEUVIMED entdecken
Qualitative StudieOpen Access · CC BY 4.0

Patient, pharmacist, and GP perspectives on identifying and managing polypharmacy: a qualitative study

Jung Yin Tsang iD, Thomas Blakeman iD, Matthew Sperrin iD, Tomazo J Kallis iD, Rupert A Payne iD, Darren M Ashcroft iD

British Journal of General Practice · 01.11.2026 · 76 (772) · e928-e937

DOI: 10.3399/bjgp.2025.0793 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift British Journal of General Practice, online erschienen am 02.07.2026. Verfasst von Jung Yin Tsang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Primary Care and Health Services Research, School of Health Sciences, The University of Manchester, Manchester, UK jungyin.tsang@mancheste…. Hauptthemen laut MEDLINE: Polypharmacy, Pharmacists, General Practitioners, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polypharmacy is a global priority owing to potential harms, including adverse drug events, hospitalisations, and high treatment burden. Overall, these outcomes have shown little improvement despite numerous interventions, indicating that current approaches to identify and manage polypharmacy remain insufficient.

Aim

To understand how polypharmacy is identified and managed in everyday primary care from patient, pharmacist, and GP perspectives. Design and setting Qualitative semi-structured interviews were conducted with 12 patients and 12 professionals (seven clinical pharmacists and five GPs) across Greater Manchester, UK.

Method

Reflexive thematic analysis was undertaken, which was supported by normalisation process theory and constant comparison as sensitisation tools.

Results

Polypharmacy was widely seen as important work but, in practice, inconsistent case-finding and unclear purposes for polypharmacy medication reviews were reported. Patients viewed medications as essential tools to sustain biopsychosocial elements of life, contrasting with practitioners’ clinical priorities to mitigate potential harm. Polypharmacy work routinely contained layers of hidden complexity, which was often overwhelming and placed a heavy emotional burden on patients and professionals. Both patients and professionals required training and experience to effectively manage these complexities. Although a protocol-driven approach was sufficient for simple medication issues, only a longer-term approach, predicated on trust, continuity, relationships, and open discussions encouraging healthy conflict, appeared to engage with deeper complexities.

Conclusion

Polypharmacy work is fraught with complexity and uncertainty, lacking standardised case-finding and clear purpose for both patients and professionals. Better models of care are needed to meet this challenge, encouraging a shift beyond a biomedically dominated protocol-driven approach to a more longitudinal and relational approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolypharmacyPharmacistsGeneral PractitionersDrug-Related Side Effects and Adverse ReactionsHumansQualitative ResearchFemaleAttitude of Health PersonnelMaleMiddle AgedUnited KingdomAgedPrimary Health CareAdult

Stichwörter der Autor:innen

general practicemedication reviewpharmacistspolypharmacyprescribingprimary health care

Autor:innen und Institutionen

  • Centre for Primary Care and Health Services Research, School of Health Sciences, The University of Manchester, Manchester, UK jungyin.tsang@manchester.ac.uk.
  • National Institute for Health and Care Research Patient Safety Research Collaboration Greater Manchester, The University of Manchester, Manchester, UK.
  • Division of Informatics, Imaging and Data Sciences, School of Health Sciences, The University of Manchester, Manchester, UK.
  • Centre for Primary Care and Health Services Research, School of Health Sciences, The University of Manchester, Manchester, UK.
  • Department of Health and Community Sciences, Faculty of Health and Life Sciences, University of Exeter Medical School, University of Exeter, Exeter, UK.
  • Division of Pharmacy and Optometry, School of Health Sciences, The University of Manchester, Manchester, UK.

ORCID-Profile: Jung Yin Tsang, Thomas Blakeman, Matthew Sperrin, Tomazo J Kallis, Rupert A Payne, Darren M Ashcroft

Zitieren

APA

Tsang, J. Y., Blakeman, T., Sperrin, M., Kallis, T. J., Payne, R. A., & Ashcroft, D. M. (2026). Patient, pharmacist, and GP perspectives on identifying and managing polypharmacy: a qualitative study. British Journal of General Practice, 76(772), e928-e937. https://doi.org/10.3399/bjgp.2025.0793

Vancouver

Tsang JY, Blakeman T, Sperrin M, Kallis TJ, Payne RA, Ashcroft DM. Patient, pharmacist, and GP perspectives on identifying and managing polypharmacy: a qualitative study. British Journal of General Practice. 2026;76(772):e928-e937. doi:10.3399/bjgp.2025.0793

BibTeX
@article{Tsang2026,
  author = {Tsang, Jung Yin and Blakeman, Thomas and Sperrin, Matthew and Kallis, Tomazo J and Payne, Rupert A and Ashcroft, Darren M},
  title = {Patient, pharmacist, and GP perspectives on identifying and managing polypharmacy: a qualitative study},
  journal = {British Journal of General Practice},
  year = {2026},
  volume = {76},
  number = {772},
  pages = {e928--e937},
  doi = {10.3399/bjgp.2025.0793}
}
Kostenlos starten →